Telix Pharmaceuticals
Melbourne · Founded 2015
About Telix Pharmaceuticals
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer.
Company Facts
- Founded: 2015
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $500K – $1M
- Total funding: $493.3M
- Funding stage: IPO
- Last round: Post-IPO Debt (Jul 2024)
- Ticker: asx:TLX
- Website: telixpharma.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/telix-pharmaceuticals-54110 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.